Pharmacokinetic interactions between the fixed-dose combinations of elvitegravir/cobicistat/tenofovir disoproxil fumarate/emtricitabine and elbasvir/grazoprevir in healthy adult participants | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Pharmacokinetic interactions between the fixed-dose combinations of elvitegravir/cobicistat/tenofovir disoproxil fumarate/emtricitabine and elbasvir/grazoprevir in healthy adult participants

Feng HP, Guo Z, Fandozzi C, et al. Pharmacokinetic interactions between the fixed-dose combinations of elvitegravir/cobicistat/tenofovir disoproxil fumarate/emtricitabine and elbasvir/grazoprevir in healthy adult participants. Clin Pharmacol Drug Dev. 2019;8(7):952-961.

Publication Type:

Journal Article

Authors:

Feng, HP; Guo, Z; Fandozzi, C; et, al

Source:

Clin Pharmacol Drug Dev, Volume 8, Issue 7, p.952-961 (2019)

Cited On:

Patients With HIV/HCV Coinfection

Export Citation:

RIS Format

Top